Name: Founder Success: UK vs. U.S. Term Sheets
Start: 2025-11-12T00:00:00Z

Founder Success: UK vs. U.S. Term Sheets

Speaking Engagements

Wednesday, November 12, 2025

HSBC HQ
London, UK

Whether you’re a founder raising capital or an investor supporting early-stage companies, understanding how term sheets differ across regions is essential to navigating international fundraising with confidence.

Join experts from Wilson Sonsini, HSBC Innovation, and New Enterprise Associates for an engaging session unpacking the key legal, commercial, and cultural distinctions between UK and U.S. term sheets, and what they mean in practice for founders, investors, and boards.

Topics will include:

Market norms and trends across regions, jurisdictions, industries and stages
Key differences in term sheet structures and clauses
Legal and regulatory considerations for cross-border deals
Investor rights and protections
Negotiation dynamics and cultural nuances
Practical case studies from recent transactions

The discussion will be followed by a Q&A and networking session.

Contacts

Nancy Farestveit

nfarestveit@wsgr.com

Presenters

Michael C. Labriola

Partner

London

Michael Labriola is a partner with Wilson Sonsini Goodrich & Rosati, where he counsels public and private technology, life sciences, and emerging growth companies through all stages of their growth. Michael has particular experience with Wilson Sonsini’s clients across the U.S. East Coast and Europe. He has a particular focus on supporting companies that undertake transformative events, such as growth financings, IPOs, acquisitions, and exit sales. Michael counsels clients in matters ranging from formation and early-stage venture financing to listings of publicly traded securities on U.S. and foreign exchanges to seasoned public offerings and private and public company acquisitions. He also has considerable experience in counseling publicly held companies on disclosure matters, SEC compliance, Nasdaq and NYSE listing matters, and other securities laws issues. In addition, Michael frequently represents investment banks, venture capital funds, and private equity firms in a broad range of investment transactions.